Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

L-NDDP

Known as: Liposomal Neodecanoic Acid Platinum Complex, Liposomal-Entrapped Cis-Bis-Neodecanoate-trans-R,R-1,2-Diaminocyclohexane Platinum (II), liposomal-NDDP 
A synthetic liposomal formulation of bis-neodecanoate diaminocyclohexane platinum (NDDP), a third-generation platinum complex analogue of cisplatin… Expand
National Institutes of Health

Related topics

Related topics

5 relations
DNADNA CrosslinkingDNA Synthesis InhibitionRNA Transcription Inhibition
Expand

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2012
Review
2012
New Cisplatin Analogues in Development
SummaryCisplatin was discovered to have cytotoxic properties in the 1960s, and by the end of the 1970s it had earned a place as… Expand
  • figure 1
  • table II
  • table I
  • table III
  • table IV
Review
2007
Review
2007
Broadening the clinical use of platinum drug–based chemotherapy with new analogues
  • L. Kelland
  • Expert opinion on investigational drugs
  • 2007
    • Corpus ID: 44788228
The three platinum-containing drugs that have been thus far approved by the FDA – cisplatin, carboplatin and oxaliplatin – have… Expand
Highly Cited
2006
Highly Cited
2006
A Phase 2 trial of the liposomal DACH platinum L-NDDP in patients with therapy-refractory advanced colorectal cancer
Purpose: L-NDDP (AroplatinTM) is a liposomal formulation of cis-bis-neodecanoato-trans-R,R-1,2-diaminocyclohexane platinum (II… Expand
  • table 1
  • figure 1
  • table 2
  • table 3
  • figure 2
Highly Cited
2005
Highly Cited
2005
Phase II study of a liposome-entrapped cisplatin analog (L-NDDP) administered intrapleurally and pathologic response rates in patients with malignant pleural mesothelioma.
PURPOSE To determine pathologic response rates to liposome-entrapped cis-bisneodecanoato-trans-R,R-1,2-diaminocyclohexane… Expand
1997
1997
Phase I clinical and pharmacological study of liposome-entrapped NDDP administered intrapleurally in patients with malignant pleural effusions.
cis-Bis-neodecanoato-trans-R,R-1,2-diaminocyclohexane platinum(II) (NDDP) is a lipophilic non-cross-resistant platinum compound… Expand
  • figure 1
  • table 1
  • table 2
  • table 3
  • table 4
1996
1996
Preparation and characterization of poly-(D,L-lactide-co-glycolide) and poly-(L-lactic acid) microspheres with entrapped pneumotropic bacterial antigens.
Poly-(lactide-co-glycolide) microspheres with entrapped antigen have shown considerable promise as controlled release vaccines… Expand
1992
1992
Synthesis and characterization of N-methyliminodiacetato trans-R,R-, trans-S,S-, and cis-1,2-diaminocyclohexane platinum (IV) complexes: crystal structure of chloro(trans-R,R-1,2-diaminocyclohexane…
The compounds, chloro(trans-R,R-1,2-diaminocyclohexane) (N-methyliminodiacetato)platinum(IV) chloride, chloro(trans-S,S-1,2… Expand
1990
1990
Topical liposomal delivery of antibiotics in soft tissue infection.
A new drug delivery system (lipid microcarriers) was studied in an experimental model of infected soft tissue wounds. Superficial… Expand
Highly Cited
1990
Highly Cited
1990
Phase I clinical and pharmacological study of liposome-entrapped cis-bis-neodecanoato-trans-R,R-1,2-diaminocyclohexane platinum(II).
cis-Bis-neodecanoato-trans-R,R-1,2-diaminocyclohexaneplatinum++ +(II) (NDDP) is a liposome dependent cisplatin analogue since the… Expand
Highly Cited
1987
Highly Cited
1987
Treatment and prophylaxis of experimental liver metastases of M5076 reticulosarcoma with cis-bis-neodecanoato-trans-R,R-1,2-diaminocyclohexaneplatinum (II) encapsulated in multilamellar vesicles.
cis-Bis-neodecanoato-trans-R,R-1,2-diaminocyclohexaneplatinum++ +-(II) (NDDP) was encapsulated in multilamellar vesicles composed… Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy, Terms of Service, and Dataset License
ACCEPT & CONTINUE